"The world has never seen a crisis of this magnitude and people are depending on science to answer the call. AbbVie’s scientists understand the stakes and are using our decades of expertise to help."
Tom Hudson, M.D., senior vice president, R&D, chief scientific officer, AbbVie
Leveraging our expertise
AbbVie’s scientific expertise has been a significant asset to our efforts in helping fight COVID-19. Our R&D team has reviewed our compounds, existing medicines and pipeline assets to evaluate their efficacy as potential treatments while simultaneously building and accelerating discovery efforts.
And we’re working with global health authorities, government health officials, universities and other biopharmaceutical companies to help address the medical impacts of the pandemic.